Sheila DeWitt

Director at Enveric Biosciences.

Earliest Form D on file: May 2026

Filed May 4, 2026

Enveric Biosciences

Non-hallucinogenic neuroplasticity drugs for depression

Biotech, Cambridge MA

Named, Director.

$5M

sold of $5M offered

Network

At Enveric Biosciences

6 people

Joseph E. Tucker
Executive Officer, Director, signed as Chief Executive Officer
Frank Pasqualone
Director
George W. Kegler
Director
Kevin M. Coveney
Executive Officer
Michael D. Webb
Director
Michael Schabacker
Director